Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 8/20 | 0.67 |
| ▸ | BRAF | P15056 | 2/20 | 0.55 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 6/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.49 |
| ▸ | JAK3 | P52333 | 2/20 | 0.48 |
| ▸ | SRC | P12931 | 2/20 | 0.48 |
| ▸ | SYK | P43405 | 2/20 | 0.48 |
| ▸ | AURKA | O14965 | 2/20 | 0.48 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.48 |
| ▸ | INSR | P06213 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | CSF1R | P07333 | 1/20 | 0.48 |
| ▸ | LYN | P07948 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1641908 | 0.95 | IGF1R (0.64) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1641738 | 0.90 | IGF1R (0.69) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1642761 | 0.90 | IGF1R (0.69) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1641798 | 0.90 | IGF1R (0.68) | IGF1RBRAFEGFRERBB2JAK3 | |
| SCHEMBL1641945 | 0.89 | IGF1R (0.67) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1640688 | 0.88 | IGF1R (0.67) | IGF1RBRAFEGFRERBB2JAK3 | |
| SCHEMBL1641968 | 0.88 | IGF1R (0.67) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1641887 | 0.88 | IGF1R (0.67) | IGF1RBRAFRIPK2EGFRERBB2 | |
| SCHEMBL1641823 | 0.87 | IGF1R (0.71) | IGF1RBRAFEGFRERBB2JAK3 | |
| SCHEMBL1641871 | 0.84 | BRAF (0.54) | IGF1RBRAFRIPK2EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | PDXK, MAP3K1, MAP4K2 | IGF1R 396/4885BRAF 151/4885RIPK2 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.